Transient autoimmune hyperthyroidism following the withdrawal of Natalizumab in patients with multiple sclerosis

By Carcelén-Gadea María   Ferrer-Garcia Juan   Cervelló Donderis Angeles  

Neurological Sciences, Vol. 34, Iss. 12, 2013-12 ,pp. : 2259-2261

Springer Publishing Company

Access to resources Recommend Favorite

Natalizumab and progressive multifocal leukoencephalopathy: migrating towards safe adhesion molecule therapy in multiple sclerosis

By Bennett Jeffrey L.  

Neurological Research, Vol. 28, Iss. 3, 2006-04 ,pp. : 291-298

Maney Publishing

Access to resources Recommend Favorite

Post-natalizumab clinical and radiological findings in a cohort of multiple sclerosis patients: 12-month follow-up

By Melis Marta   Cocco Eleonora   Frau Jessica   Lorefice Lorena   Fenu Giuseppe   Coghe Giancarlo   Mura Marco   Marrosu Maria  

Neurological Sciences, Vol. 35, Iss. 3, 2014-03 ,pp. : 401-408

Springer Publishing Company

Access to resources Recommend Favorite

Investigation of the prevalence of antibodies against neurotropic polyomaviruses BK, JC and SV40 in sera from patients affected by multiple sclerosis

By Ribeiro Tatiana   Fleury Maxime   Granieri Enrico   Castellazzi Massimiliano   Martini Fernanda   Mazzoni Elisa   Coursaget Pierre   Tognon Mauro  

Neurological Sciences, Vol. 31, Iss. 4, 2010-08 ,pp. : 517-521

Springer Publishing Company

Access to resources Recommend Favorite

Interhemispheric inhibition in patients with multiple sclerosis

By Boroojerdi B.   Hungs M.   Mull M.   Topper R.   Noth J.  

Electroencephalography and Clinical Neurophysiology/ Electromyography and Motor Control, Vol. 109, Iss. 3, 1998-06 ,pp. : 230-237

Elsevier

Access to resources Recommend Favorite